Take a look at their leader...maybe they are raising the price to pay his fines and legal bills?
http://pharmalive.com/News/index.cfm?articleid=767351
This is priceless, from the headline ... “Former CEO of KV Pharmaceutical Pleads Guilty to Misbranding Drugs and Agrees to Pay U.S. $1.9 Million in Fines and Forfeiture”
Thanks for the link. Interesting story. I would have thought that the quality control process for wrong sized pills was pretty simple. Why would the FDA let these guys have any advantage in the marketplace - let alone a monopoly on an existing compound.